{
  "meta": {
    "title": "Connective_Tissue_Disorders_Drug_Eruptions",
    "url": "https://brainandscalpel.vercel.app/connective-tissue-disorders-drug-eruptions-0302e0ee.html",
    "scrapedAt": "2025-11-29T18:24:00.736Z"
  },
  "questions": [
    {
      "id": 16962,
      "choices": [
        {
          "id": 67808,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poikiloderma</span></span></span></p>"
        },
        {
          "id": 67809,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Salt and Pepper Pigmentation</span></span></span></p>"
        },
        {
          "id": 67810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leucotrichia</span></span></span></p>"
        },
        {
          "id": 67811,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitiligo</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient comes to the OPD with the following Skin Manifestation of a Disease associated with Raynaud Phenomenon. What is the manifestation?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture6_jBW2wUn.jpg\" style=\"height:262px; width:350px\" /></p>",
      "unique_key": "Q8208828",
      "question_audio": null,
      "question_video": null,
      "map_id": 16563,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Salt and Pepper Pigmentation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: Salt and Pepper Pigmentation</span></strong><span style=\"font-size:12.0pt\"> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical scenario is suggestive of&nbsp;<strong>Systemic Sclerosis</strong>, and the skin manifestation shown is a&nbsp;<strong>Salt-and-Pepper Appearance</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An autoimmune condition with a complex pathogenesis, variable clinical presentations, and an unknown etiology is systemic sclerosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Significant disability and mortality are linked to it. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Almost all organs&nbsp;</span></strong><span style=\"font-size:12.0pt\">are impacted. Scleroderma, or&nbsp;<strong>thickened and indurated skin</strong>, is the defining characteristic of systemic sclerosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The typical white discoloration of the fingers brought on by&nbsp;<strong>vasospasm&nbsp;</strong>and the <strong>bluish&nbsp;</strong>discoloration of the fingertips are <strong>Raynaud phenomenon (</strong>first symptom) skin characteristics of systemic sclerosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The skin has a <strong>salt-and-pepper appearance</strong> when there is a loss of pigmentation, which is most noticeable on the <strong>upper back (</strong>as given in the question), chest, and scalp.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4: 1 female&nbsp;</span></strong><span style=\"font-size:12.0pt\">predominance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sclerodactyly&nbsp;</span></strong><span style=\"font-size:12.0pt\">and sclerosis extending proximal to the <strong>metacarpophalangeal joints</strong> with or without contractures.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Earliest cutaneous&nbsp;</span></strong><span style=\"font-size:12.0pt\">manifestations are <strong>non-pitting oedema </strong>and <strong>puffiness</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe&nbsp;<strong>flexion contractures &amp; </strong><strong>Muscle weakness</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loss of&nbsp;<strong>fingertip pulp </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loss of&nbsp;<strong>sweat glands</strong> in distal extremities</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vasculopathic ulcers&nbsp;</span></strong><span style=\"font-size:12.0pt\">over the bony prominences </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Expressionless facies</span></strong><span style=\"font-size:12.0pt\">, <strong>mat-like telangiectasias, microstomia</strong>, perioral furrowing, and a beak-like nose</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pruritus correlates&nbsp;</span></strong><span style=\"font-size:12.0pt\">with <strong>severity&nbsp;</strong>of cutaneous sclerosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gastroesophageal reflux disease.</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Interstitial lung disease&nbsp;</span></strong><span style=\"font-size:12.0pt\">is common in patients with <strong>Scl-70 antibodies</strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Nucleolar pattern</span></strong><span style=\"font-size:12.0pt\"> of IF (some spots of fluorescence within the nucleus and it represents antibodies to RNA) is seen in systemic sclerosis.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic sclerosis specific autoantibodies: <strong>anti-topoisomerase</strong>, <strong>anti-centromere</strong> and <strong>anti-RNA polymerase </strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Limited&nbsp;</span></strong><span style=\"font-size:12.0pt\">cutaneous systemic sclerosis or <strong>CREST</strong> syndrome: <strong>Anti-Centromere</strong> antibodies </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Poikiloderma&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a skin disorder characterized by:&nbsp;<strong>(ATP)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Atrophy</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Telangiectasia</span></strong><span style=\"font-size:12.0pt\">s</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pigment&nbsp;</span></strong><span style=\"font-size:12.0pt\">abnormalities Hypo and hyper</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is seen in <strong>ionizing radiation-damaged skin</strong> and <strong>dermatomyositis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. Sometimes the colour of the hair can change to white in the amelanotic lesions of <strong>vitiligo</strong>. It is known as <strong>Leucotrichia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. Sharply demarcated <strong>depigmented macules</strong> are a hallmark of <strong>vitiligo</strong>. It results from the loss of <strong>melanocytes.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>&#39;Salt and pepper&#39; pigmentation i</strong>s a skin manifestation associated with <strong>systemic sclerosis</strong>, a condition commonly accompanied by <strong>Raynaud&#39;s phenomenon</strong>. This pattern includes both <strong>hyperpigmented</strong> and <strong>hypopigmented</strong> areas interspersed on the skin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology, 9<sup>th</sup> Edition, Chapter 56 Page No 56.1 &ndash; 56.23</span></strong></span></span></p>",
      "correct_choice_id": 67809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16959,
      "choices": [
        {
          "id": 67796,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dilated Capillary Loops in Nail Fold can be seen</span></span></span></p>"
        },
        {
          "id": 67797,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heliotrope Rash seen in this disease is associated with Anti-Mi-2 Antibodies.</span></span></span></p>"
        },
        {
          "id": 67798,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mechanic&#39;s Hands can be seen in this disease</span></span></span></p>"
        },
        {
          "id": 67799,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Muscle Tenderness is common in this condition</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient presented with Erythema &amp; purplish tinge on upper eyelids &amp; Erythema over shawl area as shown in the image below. She also had significantly elevated serum Creatinine phosphokinase levels. Identify the FALSE statement regarding this disease?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture1_BsYJsky.jpg\" style=\"height:188px; width:300px\" /></span></span></p>",
      "unique_key": "Q4894381",
      "question_audio": null,
      "question_video": null,
      "map_id": 16560,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Muscle Tenderness is common in this condition</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The above clinical scenario is suggestive of <strong>Dermatomyositis. Muscle tenderness</strong> is <strong>NOT COMMON</strong> in this disorder.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An autoimmune condition called <strong>Dermato-Myositis (DM)</strong> primarily affects the <strong>skin and skeletal</strong> muscles. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Nail fold changes with&nbsp;<strong>periungual erythema</strong> with <strong>visible dilated capillary loops</strong> in the <strong>proximal nail fold</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">B. Gottron&#39;s papule, heliotrope rash, and shawl&nbsp;</span></strong><span style=\"font-size:12.0pt\">sign are associated with <strong>anti-Mi2 antibodies</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">C. Mechanic&#39;s hand</span></strong><span style=\"font-size:12.0pt\">: <strong>Roughening</strong> and <strong>cracking&nbsp;</strong>of the <strong>fingertip</strong> and <strong>side skin</strong> that results in <strong>scuffed</strong>, <strong>crooked lines</strong> that resemble those of a <strong>mechanic</strong> or <strong>manual labourer</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The following list includes&nbsp;<strong>several dermatomyositis symptoms</strong>:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Heliotrope rash&nbsp;</span></strong><span style=\"font-size:12.0pt\">around <strong>eyelids</strong> with a <strong>lilac hue</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gottron&#39;s papules&nbsp;</span></strong><span style=\"font-size:12.0pt\">are <strong>violaceous</strong>, <strong>erythematous papules</strong> that can appear over the <strong>elbow</strong>, <strong>knee</strong>, <strong>dorsal interphalangeal</strong> or <strong>metacarpophalangeal joints</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Gottron&#39;s sign&nbsp;</strong>is a distribution of <strong>symmetric</strong>, <strong>non-scaling</strong>, <strong>violaceous</strong>, <strong>erythematous macules</strong> or <strong>plaques</strong> that are frequently <strong>atrophic</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Shawl sign or V-sign</span></strong><span style=\"font-size:12.0pt\">: <strong>Fixed macular erythema</strong> spanning the <strong>shoulders</strong> and <strong>outer arms</strong> (<strong>Shawl distribution</strong>)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Proximal Myopathy</span></strong><span style=\"font-size:12.0pt\">: Patients have <strong>trouble</strong> performing <strong>everyday activities</strong> like <strong>climbing stairs</strong>, <strong>getting up</strong>, and <strong>lifting</strong> their <strong>arms</strong> above their heads.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Screening</span></strong><span style=\"font-size:12.0pt\">: Approximately&nbsp;<strong>20 to 40%</strong> of <strong>patients</strong> have an underlying <strong>malignancy</strong> (eg, lung, ovarian, breast) and hence screening should be done at the time of diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis</span></strong><span style=\"font-size:12.0pt\">: Laboratory evaluation of patients with dermatomyositis will reveal elevated <strong>serum creatinine kinase</strong> and <strong>antinuclear antibodies</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanic hand, Myositis, and ILD&nbsp;</span></strong><span style=\"font-size:12.0pt\">(Interstitial Lung Disease) are associated with <strong>anti-histidyl tRNA synthetase (anti-Jo-1)</strong> antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Prognosis</span></strong><span style=\"font-size:12.0pt\">: The <strong>presence </strong>of <strong>dysphagia</strong> points to a <strong>poorer prognosis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In&nbsp;<strong>dermatomyositis, muscle tenderness&nbsp;</strong>is not a common finding; instead, patients typically present with <strong>muscle weakness</strong>, a <strong>heliotrope rash</strong> associated with <strong>anti-Mi-2 antibodies</strong>, <strong>mechanic&#39;s hands,</strong> and <strong>dilated capillary loops</strong> in the nail fold.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rook&#39;s Textbook of Dermatology - Volume II-9th Edition, Chapter 53 Page no&rsquo;s 53.5, 53.6 and 53.8</span></span></strong></p>",
      "correct_choice_id": 67799,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16954,
      "choices": [
        {
          "id": 67776,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Face and Scalp are the most frequently involved sites.</span></span></span></p>"
        },
        {
          "id": 67777,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non Scarring Alopecia is seen associated with Discoid Lupus Erythematosus.</span></span></span></p>"
        },
        {
          "id": 67778,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Topical Steroids are the First Line treatment for Localised Lesions</span></span></span></p>"
        },
        {
          "id": 67779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antimalarials can be used for treatment</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All&nbsp;</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of the following statements are correct regarding Discoid Lupus Erythematosus except:</span></span></p>",
      "unique_key": "Q6213587",
      "question_audio": null,
      "question_video": null,
      "map_id": 16555,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Non Scarring Alopecia is seen associated with Discoid Lupus Erythematosus.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Non scarring alopecia is seen associated with Discoid Lupus Erythematosus. </span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A benign inflammatory skin condition called <strong>discoid lupus erythematosus</strong> usually affects the <strong>face and scalp</strong>, associated <strong>scarring alopecia (Option B)</strong> is seen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It has distinct, red, <strong>scaly patches</strong> that can vary in size. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These patches heal with atrophy, scarring, and <strong>pigmentary changes</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common type of disease is the circumscribed or <strong>discoid form</strong>, which mainly affects the <strong>cheeks, nose bridge</strong>, <strong>ears,</strong> side of the neck, and scalp. (<strong>Option A)</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The scalp-specific discoid lupus erythematosus with <strong>follicular plugging (Scarring</strong> alopecia) is depicted in the image below.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-121855.jpg\" style=\"height:186px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The skin lesions in <strong>discoid or chronic cutaneous lupus erythematosus</strong> are well-defined erythematous patches with <strong>adherentscaling</strong> and <strong>peripheral hyperpigmentation</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The underside of the scale reveals <strong>horny plugs</strong> that have occupied <strong>dilated pilosebaceous</strong> canals when the scale is removed. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This sign is known as the <strong>&quot;tin-tack&quot; sign.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>first-line</strong> treatment for localized lesions is <strong>topical corticosteroids. (Option C)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hydroxychloroquine and chloroquine&nbsp;</span></strong><span style=\"font-size:12.0pt\">are oral <strong>antimalarial </strong>drugs that can be used along with oral steroids and have a good response rate. <strong>(Option D)</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Discoid lupus erythematosus (DLE)</strong> typically presents with <strong>scarring alopecia</strong> when it affects the scalp, distinguishing it from non-scarring forms of alopecia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rook&#39;s Textbook of Dermatology 9th Edition, Chapter 51, Page no&rsquo;s 51.4-51.10</span></span></strong></p>",
      "correct_choice_id": 67777,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16955,
      "choices": [
        {
          "id": 67780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scarring Papulo-Squamous Eruption</span></span></span></p>"
        },
        {
          "id": 67781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-Scarring Papulo-Squamous Eruption</span></span></span></p>"
        },
        {
          "id": 67782,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Annular Polycyclic Lesions</span></span></span></p>"
        },
        {
          "id": 67783,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vesiculobullous Lesions</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young woman arrived at the OPD with the following Annular Polycyclic Rash. She also complained of Myalgia, Arthralgia, and Hair Loss. Her medical history was significant for sun aggravating her Skin complaints. A diagnosis of SCLE is considered. Which of the following is the most common cutaneous presentation of this condition?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture2_E0ejbOV.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q4996578",
      "question_audio": null,
      "question_video": null,
      "map_id": 16556,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Non-Scarring Papulo-Squamous Eruption</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: Non-Scarring Papulo-Squamous Eruption </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Subacute Cutaneous Lupus Erythematosus&nbsp;</span></strong><span style=\"font-size:12.0pt\">presents most commonly as a&nbsp;<strong>Non-Scarring Papulo-Squamous</strong> <strong>Eruption</strong>. It can also present as <strong>annular polycyclic</strong> <strong>lesions</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sites of lesions</span></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Above the Waist</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Around the Neck</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">On the Trunk</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Outer Aspects of the Arms</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this subgroup,&nbsp;<strong>Antibodies to the Ro (SS-A)&nbsp;</strong>Antigen are&nbsp;<strong>almost always present</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Its primarily a&nbsp;<strong>Cutaneous Disease</strong> and generally has a&nbsp;<strong>favourable Prognosis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image below shows&nbsp;<strong>Psoriasiform Lesions&nbsp;</strong>of&nbsp;<strong>Subacute Cutaneous Lupus Erythematosus</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture3_yxkVj31.jpg\" style=\"height:454px; width:300px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Scarring papulosquamous eruption</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While&nbsp;<strong>cutaneous lesions&nbsp;</strong>in&nbsp;<strong>systemic lupus erythematosus (SLE)&nbsp;</strong>can sometimes&nbsp;<strong>scar</strong>, particularly in the case of <strong>discoid lupus</strong>, <strong>SCLE</strong> typically presents with <strong>non-scarring lesions</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Annular polycyclic lesions</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This option is&nbsp;<strong>not</strong> the&nbsp;<strong>most common presentation</strong>, making it&nbsp;<strong>incorrect</strong> for the purpose of this question. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Although annular polycyclic lesions are&nbsp;<strong>characteristic</strong> of <strong>SCLE</strong>, they occur in a <strong>smaller proportion of patients (about one-third)&nbsp;</strong>compared to the papulosquamous eruption.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vesiculobullous lesions</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vesiculobullous lesions are&nbsp;<strong>not typically seen&nbsp;</strong>in SCLE. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These types of lesions are more commonly associated with&nbsp;<strong>other dermatological conditions&nbsp;</strong>like&nbsp;<strong>bullous pemphigoid</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The&nbsp;<strong>most common</strong> cutaneous presentation of <strong>subacute cutaneous lupus erythematosus (SCLE</strong>) is a <strong>non-scarring papulosquamous</strong> eruption, which is seen in the <strong>majority</strong> of patients, while a smaller percentage presents with <strong>annular polycyclic lesions.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rook&#39;s Textbook of Dermatology 9th Edition, Chapter 51, Page no 51.11-13</span></span></strong></p>",
      "correct_choice_id": 67781,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16956,
      "choices": [
        {
          "id": 67784,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Photosensitivity is the most common Cutaneous Manifestation</span></span></span></p>"
        },
        {
          "id": 67785,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Salmon Rash is seen in this condition</span></span></span></p>"
        },
        {
          "id": 67786,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Smith (anti-Sm) Antibodies are considered to be most specific for SLE</span></span></span></p>"
        },
        {
          "id": 67787,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-ds DNA correlates with Disease Activity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following statements are correct regarding SLE except?</span></span></p>",
      "unique_key": "Q9751474",
      "question_audio": null,
      "question_video": null,
      "map_id": 16557,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Salmon Rash is seen in this condition</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: Salmon rash is seen in this condition</span></strong><span style=\"font-size:12.0pt\"> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Salmon rash&nbsp;</span></strong><span style=\"font-size:12.0pt\">is seen in <strong>adult-onset of Still&#39;s disease</strong>, not SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>most common </strong>cutaneous manifestation of <strong>Systemic Lupus Erythematosus</strong> is <strong>photosensitivity</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In decreasing order, the cutaneous manifestations in SLE are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1.&nbsp;<strong>Photosensitivity (Option A)</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2.&nbsp;<strong>Raynaud&#39;s phenomenon</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3.&nbsp;<strong>Malar rash</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4. Chronic urticaria &gt;36 hrs</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">5. Non-scarring alopecia</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6. Painless ulcers over palate</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SLE is more prevalent in&nbsp;<strong>women (7:1 to 15:1).&nbsp;</strong>It is connected to the classic erythematous rash known as&nbsp;<strong>malar/butterfly</strong> rash, which typically&nbsp;<strong>spares</strong> the <strong>nasolabial folds</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">There may also be discoid rashes that <strong>resemble discoid lupus erythematosus</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Malar / Butterfly Rash.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture4_etqTB5h.jpg\" style=\"height:179px; width:350px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Some important points regarding <strong>Antibodies in SLE</strong>:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-Smith (anti-Sm)&nbsp;</span></strong><span style=\"font-size:12.0pt\">antibodies <strong>(Option C): Most specific</strong> for SLE &amp; included in ACR criteria. (Its levels do NOT correlate with disease activity)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">ANA&nbsp;</span></strong><span style=\"font-size:12.0pt\">antibodies: <strong>Most sensitive</strong> antibodies.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rim pattern&nbsp;</span></strong><span style=\"font-size:12.0pt\">of ANA positivity is specific for SLE.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-ds DNA (Option D)&nbsp;</span></strong><span style=\"font-size:12.0pt\">levels correlates with <strong>disease </strong></span><strong><span style=\"font-size:12.0pt\">activity.</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-Ro&nbsp;</span></strong><span style=\"font-size:12.0pt\">antibodies are associated with <strong>photosensitivity.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Glomerular Capillary Loops&nbsp;</span></strong><span style=\"font-size:12.0pt\">appearing as circumferentially thickened&nbsp;<strong>&quot;Wire Loop&quot; lesion</strong>, is classically seen in&nbsp;<strong>class IV</strong> or diffuse proliferative <strong>Lupus Nephritis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Adult-Onset of Still&#39;s&nbsp;</span></strong><span style=\"font-size:12.0pt\">Disease, is a rare systemic inflammatory disease characterized by the classic triad of:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Persistent high Spiking Fever</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Joint Pain</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Salmon Rash (Option B)</span></strong></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;<strong>&#39;Salmon Rash&#39;&nbsp;</strong>is not a feature of systemic lupus erythematosus (SLE) but is seen in <strong>adult-onset Still&#39;s disease</strong>, while SLE commonly presents with <strong>photosensitivity&nbsp;</strong>and may show specific antibodies like <strong>Anti-Sm</strong> and <strong>Anti-dsDNA,</strong> which correlates with <strong>disease activity.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rook&#39;s Textbook of Dermatology - Volume II-9th Edition, Chapter 51 Page no 51.15, 51.21, 51.34</span></span></strong></p>",
      "correct_choice_id": 67785,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16957,
      "choices": [
        {
          "id": 67788,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Approximately 10% of the Infants Manifest Cutaneous Lesions</span></span></span></p>"
        },
        {
          "id": 67789,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rash Resolves over few months with Scarring</span></span></span></p>"
        },
        {
          "id": 67790,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phototherapy can be safely given to this Neonate</span></span></span></p>"
        },
        {
          "id": 67791,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common Cutaneous finding is Raccoon Sign</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding Neonatal Lupus Erythematosus?</span></span></p>",
      "unique_key": "Q6831627",
      "question_audio": null,
      "question_video": null,
      "map_id": 16558,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) The most common Cutaneous finding is Raccoon Sign</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The most common Cutaneous finding is raccoon sign</span></strong><span style=\"font-size:12.0pt\"> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An erythematous, slightly scaly eruption on the face and&nbsp;<strong>periorbital</strong> skin (also known as the <strong>&quot;Raccoon Sign,&quot; &quot;Owl Eye,&quot; or &quot;Eye Mask&quot;)&nbsp;</strong>is the most typical symptom of&nbsp;<strong>Neonatal Lupus Erythematosus (NLE).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Neonatal Lupus Erythematosus (NLE):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NLE is a well-known subtype of lupus erythematosus that is thought to be brought on by&nbsp;<strong>maternal antibodies&nbsp;</strong>crossing the <strong>placenta.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Skin <strong>lesions&nbsp;</strong>and <strong>congenital heart block (CHB)&nbsp;</strong>are the <strong>most common clinical manifestations</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Skin lesions</span></strong><span style=\"font-size:12.0pt\">, which may be present at birth or develop in the first few weeks of life, are present in about <strong>50% of new-borns</strong> (NOT 10%).&nbsp;<strong>(Option A)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">UV exposure&nbsp;</span></strong><span style=\"font-size:12.0pt\">may make the eruption worse (So <strong>Phototherapy</strong>, if needed, has to be administered with&nbsp;<strong>Caution).<br />\r\n\t(Option C)</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The rash gets better over the&nbsp;<strong>first few months&nbsp;</strong>of life and usually goes away <strong>without&nbsp;</strong>leaving any <strong>scars</strong> by the age of <strong>twelve months</strong>. Skin conditions are frequently minor and do not need to be treated.<strong> (Option B)</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image given below shows typical <strong>raccoon&nbsp;</strong>eyelid lesions in neonatal lupus erythematosus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture5_K0xhtPI.jpg\" style=\"height:277px; width:350px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Neonatal lupus erythematosus</strong>, the most common cutaneous manifestation is the <strong>&#39;raccoon sign&#39;,</strong> presenting as <strong>erythematous, slightly scaly</strong> lesions on the <strong>face</strong> and <strong>periorbital skin</strong>, which typically resolve <strong>without scarring.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rook&#39;s Textbook of Dermatology 9th Edition, Chapter 51, Page no&rsquo;s 51.37 and 51.38</span></strong></span></span></p>",
      "correct_choice_id": 67791,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16963,
      "choices": [
        {
          "id": 67812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Multiforme (EMF) is the Diagnosis</span></span></span></p>"
        },
        {
          "id": 67813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Multiforme Minor is the most common form</span></span></span></p>"
        },
        {
          "id": 67814,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Distribution of Target Lesions is mainly over Acral Sites</span></span></span></p>"
        },
        {
          "id": 67815,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">NSAIDs are the most common Triggering Factor for EMF</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are correct about the below given condition except?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture7_BC1RZJr.jpg\" style=\"height:227px; width:300px\" /></span></span></p>",
      "unique_key": "Q7314893",
      "question_audio": null,
      "question_video": null,
      "map_id": 16564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) NSAIDs are the most common Triggering Factor for EMF</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given image shows characteristic <strong>target lesions</strong> of <strong>Erythema Multiforme (EMF) (Option A)</strong>, (which most commonly occurs following a <strong>herpes simplex virus infection</strong> (NOT due to drugs)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Erythema Multiforme</span></strong><span style=\"font-size:12.0pt\">: Self-limiting <strong>cytotoxic</strong> dermatitis resulting from <strong>Delayed type of hypersensitivity</strong>. It most commonly occurs following an&nbsp;<strong>Infection</strong>&gt;&gt; drug intake.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Clinical Features</span></strong><span style=\"font-size:12.0pt\">: Classic acral&nbsp;<strong>iris or &#39;target lesions&#39;</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture8_L4WJqHc.jpg\" style=\"height:159px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lesions are distributed preferentially on the&nbsp;<strong>distal extremities (Option C).&nbsp;</strong>Oral and genital <strong>mucosal</strong> membranes lesions are associated with <strong>erosions.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesions appear in successive <strong>crops</strong> for a few days and <strong>fade in 1-2 weeks</strong>, sometimes leaving dusky discoloration.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The common <strong>triggers</strong> are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Herpes simplex infection (Most Common) (Option D)</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mycoplasma infection</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bacterial infections</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fungal infections</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vaccinations</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Malignancy- carcinoma, lymphoma, leukaemia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drugs- sulphonamides, rifampicin, penicillin&rsquo;s, hydantoin derivatives</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Miscellaneous- lupus erythematosus (Rowell Syndrome), sarcoidosis, polyarteritis nodosa</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture9_AaOs8kt.jpg\" style=\"height:177px; width:400px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Erythema Multiforme</strong> is often triggered by <strong>infections</strong>, particularly <strong>herpes simplex virus</strong>, rather than NSAIDs, and it commonly presents as <strong>Erythema Multiforme minor</strong> with <strong>target lesions</strong> concentrated on <strong>acral sites.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">s: Rook&#39;s Textbook of Dermatology 9th Edition Chapter 47, Page no 47.1-5</span></strong></span></span></p>",
      "correct_choice_id": 67815,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16964,
      "choices": [
        {
          "id": 67816,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Steven Johnson Syndrome </span></span></span></p>"
        },
        {
          "id": 67817,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Toxic Epidermal Necrolysis&nbsp; </span></span></span></p>"
        },
        {
          "id": 67818,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fixed Drug Eruption</span></span></span></p>"
        },
        {
          "id": 67819,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pemphigus Vulgaris</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 19-year-old patient with neurocysticercosis develops generalised peeling of skin except palms &amp; soles &amp; severe oral &amp; genital involvement starting after taking seizure medication. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q7059428",
      "question_audio": null,
      "question_video": null,
      "map_id": 16565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Toxic Epidermal Necrolysis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">B: Toxic Epidermal Necrolysis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Stevens-Johnson syndrome and Toxic Epidermal Necrolysis (TEN)&nbsp;</span></strong><span style=\"font-size:12.0pt\">are </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute life threatening&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">severe&nbsp;<strong>mucocutaneous adverse drug reactions</strong></span><span style=\"font-size:12.0pt\">, usually to drugs, characterized by&nbsp;<strong>blistering and epithelial sloughing</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drugs that can cause SJS/TEN are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Allopurinol</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">NSAIDs-&nbsp;</span></strong><span style=\"font-size:12.0pt\">Oxicam group</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-Epileptics </span></strong><span style=\"font-size:12.0pt\">- Phenobarbital, Phenytoin, Carbamazepine, Lamotrigine</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antibiotics</span></strong><span style=\"font-size:12.0pt\"> - Penicillin&rsquo;s, Cephalosporins, Sulfamethoxazole, Sulfasalazine, Nevirapine.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The two terms&nbsp;<strong>Stevens Johnson Syndrome&nbsp;</strong>&amp;&nbsp;<strong>Toxic Epidermal Necrolysis&nbsp;</strong>describe phenotypes within a&nbsp;<strong>severity spectrum</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Depending upon <strong>BSA&nbsp;</strong>involved we can see <strong>3 possibilities&nbsp;</strong>as given below.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture10_Ys3nQek.jpg\" style=\"height:176px; width:400px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stevens Johnson Syndrome &amp; Toxic Epidermal Necrolysis can be associated with <strong>Conjunctivitis, Cheilitis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Painful <strong>erosions</strong> over oral mucosa, covered by <strong>hemorrhagic crusts</strong>, which <strong>bleed&nbsp;</strong>on <strong>peeling</strong> can occur in these conditions as shown below:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture11_J0k99RV.jpg\" style=\"height:126px; width:300px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In <strong>Lyell&#39;s syndrome / Toxic Epidermal Necrolysis</strong>, diffuse generalized epidermal <strong>detachment</strong> is seen with extensive mucosal involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Steven Johnson Syndrome (SJS)</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SJS is a <strong>severe mucocutaneous reaction</strong>, often to <strong>medication</strong>s, but it is characterized by <strong>less extensive</strong> skin detachment than TEN (<strong>less than 10% body surface area</strong>). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Given the &quot;<strong>generalised peeling of skin</strong>&quot;, SJS is less likely than TEN.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Fixed drug eruption</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This condition typically presents with solitary or a few well-demarcated plaques that <strong>recur at the same site</strong> with <strong>re-exposure</strong> to the offending drug, which does not match the described extensive peeling and mucosal involvement.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pemphigus vulgaris</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pemphigus vulgaris is an&nbsp;<strong>autoimmune blistering</strong> disorder that involves the <strong>skin and mucous</strong> membranes, but it does not typically present with generalised skin peeling as a reaction to medication.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Toxic Epidermal Necrolysis i</strong>s a <strong>severe drug reaction </strong>characterized by <strong>widespread skin peeling</strong>, including <strong>severe oral and genital mucosal </strong>involvement.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Refs</u>:&nbsp;&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rook&#39;s Textbook of Dermatology 9th Edition, Chapter 119 Page Nos 119.13-119.14</span></span></strong></p>",
      "correct_choice_id": 67817,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16960,
      "choices": [
        {
          "id": 67800,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chikungunya </span></span></span></p>"
        },
        {
          "id": 67801,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Post Inflammatory Hyperpigmentation</span></span></span></p>"
        },
        {
          "id": 67802,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fixed Drug Eruption</span></span></span></p>"
        },
        {
          "id": 67803,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drug Hypersensitivity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55 -year-old woman presents with rash over her lips as shown in image below, after she had taken NSAIDs for her joint pain. She had reported that she developed the same rash in the same location 5 months ago when she took the same drugs for back pain. What is the most likely diagnosis?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture12_61cJM38.jpg\" style=\"height:283px; width:300px\" /></span></span></p>",
      "unique_key": "Q1949342",
      "question_audio": null,
      "question_video": null,
      "map_id": 16561,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Fixed Drug Eruption</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: Fixed Drug Eruption</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given clinical situation suggests a diagnosis of a <strong>Fixed drug eruption</strong>. Fixed drug eruption is one of the <strong>most common forms</strong> of drug induced exanthems</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Fixed drug eruption (FDE)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FDE is a <strong>drug eruption</strong> distinguished by its recurrence at the <strong>same sites on rechallenge</strong>, its <strong>short latency</strong> and <strong>benign nature</strong>, hence their <strong>site</strong> on the <strong>skin</strong> is <strong>fixed</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">FDE typically <strong>presents 30 min</strong> to <strong>8 h</strong> <strong>after</strong> <strong>drug exposure</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Typically, <strong>FDE</strong> presents as a <strong>sharply defined</strong>, <strong>round</strong> or <strong>oval</strong> <strong>erythematous and oedematous plaque</strong> which evolves to <strong>become dusky</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Violaceous&nbsp;</span></strong><span style=\"font-size:12.0pt\">and occasionally <strong>vesicular</strong> or <strong>bullous</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Classically <strong>hyperpigmentation</strong> occurs after <strong>lesions heal.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Most common cause:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">NSAIDs - On Lips</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cotrimoxazole - On Genitals</span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute onset pigmentary changes after NSAID use point toward the diagnosis of FDE. <strong>NSAID&#39;s are one of the most common drugs causing FDE. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The majority of FDE is <strong>self-limiting </strong>with an <strong>excellent prognosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note: The <strong>generalized bullous form of FDE</strong> should be differentiated from <strong>toxic epidermal necrolysis</strong> by prior similar <strong>history</strong>, absence of <strong>target</strong> lesions, and no involvement of <strong>mucosal</strong> surfaces.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The image below shows <strong>hyperpigmentation</strong> on the <strong>Lips</strong> &amp; <strong>Glans penis</strong> developing <strong>simultaneously</strong> &amp; <strong>healing</strong> at the <strong>same time frame</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture13_xPOoH1X.jpg\" style=\"height:299px; width:300px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Chikungunya fever</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>nose</strong> and <strong>cheeks</strong> show <strong>signs</strong> of <strong>post-chikungunya</strong> <strong>hyperpigmentation</strong> on the <strong>Centro-facial face</strong> (so-called &quot;<strong>chik sign</strong>&quot;). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">After the <strong>fever</strong> has <strong>subsided</strong>, the pigmentary changes <strong>appear</strong> and could last for <strong>three to six months</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, the question stem describes how pigmentary changes start to manifest after a few days. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, during the <strong>acute febrile phase</strong>, these patients will not experience any preceding erythema or eruption over the affected areas.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Post-inflammatory hyperpigmentation (PIH</span></strong><span style=\"font-size:12.0pt\">) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is an <strong>acquired form</strong> of <strong>hyper melanosis</strong> that develops as a <strong>result</strong> of <strong>cutaneous injury</strong> or <strong>inflammation</strong>, such as <strong>impetigo, atopic dermatitis, or acne vulgaris.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Drug hypersensitivity</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is an <strong>immune-mediated reaction</strong> to a <strong>drug</strong> of which symptoms <strong>ranging</strong> from <strong>mild to severe include rash, anaphylaxis, </strong>and<strong> serum sickness.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Fixed drug eruption</strong> by the <strong>recurrence</strong> of a <strong>localized rash</strong> at the <strong>same site</strong> upon <strong>re-exposure</strong> to an offending drug, such as <strong>NSAIDs.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">s: Rooks Textbook of Dermatology, 9<sup>th</sup> Edition, Chapter 118 Page No 118.12</span></span></strong></p>",
      "correct_choice_id": 67802,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34172,
      "choices": [
        {
          "id": 136519,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Annulare</span></span></span></p>"
        },
        {
          "id": 136520,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Migrans</span></span></span></p>"
        },
        {
          "id": 136521,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Marginatum</span></span></span></p>"
        },
        {
          "id": 136522,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Multiforme</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old woman presents to the clinic with a 5-day history of a spreading rash. She reports that it began as a small red spot on her thigh that has expanded progressively and now measures approximately 15 cm in diameter. The lesion is not painful but feels warm to the touch. She recalls hiking in a heavily wooded area in the North-eastern United States two weeks prior. On examination, you observe a target like lesions as shown in the image below. Which of the following is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture14_hryUQNN.jpg\" style=\"height:248px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2126221",
      "question_audio": null,
      "question_video": null,
      "map_id": 22653,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Erythema Migrans</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: Erythema Migrans</span></strong><span style=\"font-size:12.0pt\">. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is the <strong>hallmark rash</strong> associated with <strong>Lyme disease</strong>, which is caused by the <strong>spirochete Borrelia burgdorferi</strong> and transmitted by <strong>Ixodes ticks</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s history of <strong>hiking</strong> in an <strong>endemic area</strong>, along with the characteristic <strong>&quot;bullseye&quot; rash</strong>, supports this diagnosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema migrans typically appears within <strong>7-14 days</strong> after the <strong>tick bite</strong> and <strong>slowly expands</strong> over <strong>days</strong> to <strong>weeks</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Erythema Annulare</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is characterized by <strong>ring-shaped</strong> lesions shown in the image below but <strong>lacks the Bulls eye appearance</strong> and is <strong>not</strong> associated with a history of <strong>tick exposure.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture15_W2tAvFN.jpg\" style=\"height:231px; width:350px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Erythema Marginatum</span></strong><span style=\"font-size:12.0pt\">: It is associated with <strong>rheumatic fever </strong>and presents with <strong>pink rings </strong>on the <strong>trunk</strong> and <strong>inner surfaces </strong>of the <strong>limbs </strong>as shown in the image below, not the expanding lesion described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture16_0u7vjfc.jpg\" style=\"height:244px; width:350px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Erythema Multiforme</span></strong><span style=\"font-size:12.0pt\">: It is a <strong>hypersensitivity reaction </strong>associated with certain <strong>infections</strong>, <strong>medications</strong>, and other triggers and presents with multiple <strong>target lesions mainly </strong>involving <strong>extremities </strong>as shown in the image below.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture17_0Dux1WM.jpg\" style=\"height:237px; width:350px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-133208.jpg\" style=\"height:837px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Erythema Migrans</strong>&nbsp;is the characteristic rash of <strong>Lyme disease</strong>, typically presenting as a <strong>circular rash</strong> with <strong>central clearing</strong> following a <strong>tick bite</strong> in endemic areas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rooks textbook of dermatology- 9<sup>th</sup> Edition page no 50.70</span></strong></span></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bolognia Textbook of Dermatology 4<sup>th</sup> edition Page no 326</span></span></strong></p>",
      "correct_choice_id": 136520,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34176,
      "choices": [
        {
          "id": 136535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Annulare</span></span></span></p>"
        },
        {
          "id": 136536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Marginatum</span></span></span></p>"
        },
        {
          "id": 136537,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Multiforme</span></span></span></p>"
        },
        {
          "id": 136538,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema Nodosum</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-year-old woman presents to the Derma OPD with complaints of a rash on the palms and trunk for the past 2 weeks. One week prior to the onset of her symptoms, she was diagnosed with a urinary tract infection, for which she was prescribed Trimethoprim sulfamethoxazole. Now, on general physical examination her BP is 120/80, temperature is 100.2 degrees F, pulse is 98/minute, and her respiration is 16/minute. On examination of her skin, maculopapular rash having a dusky center with multiple rings is noted as shown in the image below.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture18.jpg\" style=\"height:203px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1067967",
      "question_audio": null,
      "question_video": null,
      "map_id": 22656,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Erythema Multiforme</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: Erythema Multiforme</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is the most likely diagnosis given the history of <strong>medication use (Trimethoprim sulfamethoxazole)</strong> and the description of a maculopapular rash with a <strong>dusky center</strong> and <strong>multiple rings (Multiple Target Lesions)</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema multiforme is often a <strong>hypersensitivity reaction</strong> to medications, infections, or other triggers.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Erythema Annulare:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This term is <strong>less commonly used</strong> and may refer to a pattern seen in several conditions, but the <strong>description</strong> of <strong>rings</strong> with <strong>dusky centers</strong> is <strong>more typical</strong> of <strong>erythema multiforme</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Erythema Marginatum:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This type of erythema is most often associated with <strong>rheumatic fever</strong> and is characterized by <strong>non-pruritic, pink rings on the trunk</strong> and <strong>inner aspects</strong> of the <strong>limbs</strong>, which do not fit the description provided.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Erythema Nodosum:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Presents as <strong>tender red nodules</strong>, usually on the <strong>shins</strong>, and is not described as having multiple rings or a dusky center.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-133923.jpg\" style=\"height:792px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Erythema multiforme</strong>&nbsp;is characterized by <strong>target lesions</strong>&mdash;a d<strong>usky central area </strong>surrounded by a <strong>paler ring</strong> and a <strong>dark outermost ring</strong>&mdash;and is often a reaction to certain <strong>medications or infections</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rooks textbook of dermatology- 9<sup>th</sup> Edition page no 47.11- 47.17</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bolognia Textbook of Dermatology 4<sup>th</sup> edition Page no 334</span></strong></span></span></p>",
      "correct_choice_id": 136537,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34178,
      "choices": [
        {
          "id": 136543,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alanine Amino Transferase &gt;40 IU/L</span></span></span></p>"
        },
        {
          "id": 136544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urea &gt; 10 mmol/L</span></span></span></p>"
        },
        {
          "id": 136545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Potassium &gt; 2.5 mEq/L</span></span></span></p>"
        },
        {
          "id": 136546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sodium 140 mEq/L</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old patient with a history of antiepileptic medication use presents with widespread bullous skin lesions with extensive denudation of skin covering over 60% of body surface area as shown in the image below, mucosal involvement, and a positive Pseudo Nikolsky sign. Laboratory investigations reveal the following abnormalities. Which of the following serological findings is most useful in assessing the prognosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture19_G6EJhLt.jpg\" style=\"height:184px; width:300px\" /></p>",
      "unique_key": "Q1069698",
      "question_audio": null,
      "question_video": null,
      "map_id": 22657,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Urea &gt; 10 mmol/L</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Toxic Epidermal Necrolysis (</span></strong><strong><span style=\"font-size:12.0pt\">TEN)</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is a <strong>severe</strong> and <strong>life-threatening</strong> condition characterized by <strong>widespread bullous skin lesions </strong>with <strong>extensive denudation</strong>, <strong>mucosal</strong> <strong>involvement</strong>, and a <strong>positive Nikolsky sign</strong> (or in this case, a <strong>&quot;Pseudo Nikolsky&rsquo;s&quot; sign</strong>). Assessing the prognosis in TEN is crucial for clinical management.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most useful serological finding for <strong>assessing</strong> the <strong>prognosis</strong> in <strong>TEN</strong> is <strong>elevated urea levels (Option B)</strong> since it indicates the presence of <strong>acute kidney injury</strong>, which is a significant predictor of a <strong>poor prognosis</strong> in this condition.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-135330.jpg\" style=\"height:642px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">BSA = Body Surface Area</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Alanine aminotransferase &gt;40 IU/L &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated liver enzymes may be seen in some cases due to <strong>systemic involvement, </strong>but they are <strong>not</strong> the primary indicator for assessing the prognosis in TEN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Potassium &gt; 2.5 mEq/L &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated potassium levels can occur in TEN due to <strong>tissue damage </strong>and <strong>cell breakdown </strong>but are <strong>not </strong>as useful in assessing the prognosis compared to renal function.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Sodium 140 mEq/L &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Normal sodium levels do <strong>not </strong>provide specific information about the prognosis in TEN.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Elevated <strong>urea levels (&gt;10 mmol/L)</strong> are a valuable <strong>serological finding</strong> for assessing the <strong>prognosis</strong> in toxic epidermal necrolysis <strong>(TEN)</strong> because they indicate the presence of <strong>acute kidney injury</strong>, a significant predictor of <strong>poor outcomes</strong> in this severe skin condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Page No 119.3- 119.20</span></strong></span></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bolognia Textbook of Dermatology 4<sup>th</sup> edition Page No 341</span></span></strong></p>",
      "correct_choice_id": 136544,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34181,
      "choices": [
        {
          "id": 136555,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bacterial Infection</span></span></span></p>"
        },
        {
          "id": 136556,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral Infection</span></span></span></p>"
        },
        {
          "id": 136557,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Drug Induced</span></span></span></p>"
        },
        {
          "id": 136558,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Idiopathic </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 50-year-old patient presents with severe bullous skin lesions with extensive denudation of skin covering over 60% of the body surface area, mucosal involvement as shown in the image below, and a positive Pseudo Nikolsky sign. On further evaluation, a thorough medication history reveals recent use of antibiotics for gastrointestinal complaints. What is the most likely aetiology of this patient&#39;s condition?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture20.jpg\" style=\"height:317px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8616741",
      "question_audio": null,
      "question_video": null,
      "map_id": 22658,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C) Drug Induced.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: Drug induced &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug-induced&nbsp;</span></strong><span style=\"font-size:12.0pt\">reactions, especially <strong>adverse drug reactions</strong>, are the most common cause of <strong>TEN</strong>. Given the <strong>recent use of antibiotics</strong> and the characteristic clinical presentation, drug induced TEN is the most likely aetiology in this case.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Medications Most Frequently Associated with Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-140732.jpg\" style=\"height:362px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Toxic epidermal necrolysis (TEN)&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a severe and potentially <strong>life-threatening</strong> condition characterized by <strong>widespread bullous skin lesions</strong>, <strong>mucosal</strong> involvement, and a <strong>positive Pseudo Nikolsky sign</strong>. Identifying the underlying cause is crucial for proper management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A) Bacterial Infection &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bacterial infections can cause <strong>skin conditions</strong>, but they are not the primary cause of TEN. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TEN is typically associated with <strong>medications</strong> and, less commonly, viral infections.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B) Viral Infection &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Although viral infections can lead to various skin manifestations, they are not the primary cause of TEN. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Medications&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>drug-induced reactions</strong>, such as antibiotics, are more common <strong>triggers</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D) Idiopathic &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Idiopathic means the cause is <strong>unknown</strong>, but in the <strong>majority</strong> of <strong>TEN cases</strong>, a specific trigger can be identified, such as <strong>medication use</strong> or, less commonly, <strong>viral infections.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Toxic Epidermal Necrolysis (TEN) is most commonly <strong>drug-induced</strong>, often triggered by medications like <strong>antibiotics</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identifying the <strong>causative drug</strong> is crucial for management and <strong>preventing</strong> further exposure.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Page No 119.3- 119.20</span></strong></span></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bolognia Textbook of Dermatology 4<sup>th</sup> edition Page No 341</span></span></strong></p>",
      "correct_choice_id": 136557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34182,
      "choices": [
        {
          "id": 136559,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Can occur in association with Diabetes</span></span></span></p>"
        },
        {
          "id": 136560,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Associated with Sclerodactyly and Raynaud&rsquo;s Phenomenon</span></span></span></p>"
        },
        {
          "id": 136561,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Dermis is 3-4 times thicker than normal</span></span></span></p>"
        },
        {
          "id": 136562,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythema and Peaud&#39;orange Appearance of the Skin can be seen</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following statements is False regarding Scleredema?</span></span></span></p>",
      "unique_key": "Q5580786",
      "question_audio": null,
      "question_video": null,
      "map_id": 22659,
      "difficulty_level": "difficult",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Associated with Sclerodactyly and Raynaud&rsquo;s Phenomenon.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sclerodactyly and Raynaud&rsquo;s Phenomenon&nbsp;</span></strong><span style=\"font-size:12.0pt\">are <strong>associated with Scleroderma </strong>(NOT with scleredema).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Scleredema&nbsp;</span></strong><span style=\"font-size:12.0pt\">&amp; <strong>Scleroderma</strong> are different diseases.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-141801.jpg\" style=\"height:269px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Scleredema is not associated&nbsp;</span></strong><span style=\"font-size:12.0pt\">with <strong>sclerodactyly, Raynaud&rsquo;s phenomenon, nail fold capillary changes or serum autoantibodies.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Scleredema:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Synonyms - <strong>Scleredema adultorum of Buschke, Scleredema Diabeticorum</strong>.</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scleredema results in <strong>taut skin with noticeable symmetrical, diffuse progressive, non-pitting induration</strong>. This is because the dermis has expanded, <strong>mucin has been deposited</strong>, and the subcutaneous fat has been replaced by coarse collagen fibers.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It commonly presents with <strong>erythema and induration</strong> on the <strong>posterior neck and back</strong>, along with a <strong>peaud&#39;orange</strong> appearance of the skin. Interestingly, the hands and feet remain unaffected. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The condition is characterized by a <strong>3-4 times thicker dermis</strong> than usual, caused by <strong>dysfunctional fibroblasts</strong> leading to <strong>increased type 1 collagen synthesis</strong>, but without fibroblast proliferation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most prevalent type of this condition is associated with <strong>diabetes mellitus</strong>, and it is more commonly found in <strong>men</strong> compared to other forms that are more frequently seen in women. The <strong>accumulation</strong> of <strong>collagen</strong> is attributed to <strong>irreversible</strong> <strong>glycosylation</strong> of <strong>collagen</strong> and its <strong>resistance</strong> to <strong>degradation</strong> by <strong>collagenase</strong>.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture21_2jsR0Rh.jpg\" style=\"height:255px; width:350px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Against an <strong>erythematous backdrop</strong>, the <strong>image depicts scleredema</strong> in a <strong>diabetic patient</strong> with <strong>firm</strong>, <strong>non-pitting edema</strong> with <strong>induration</strong> on the <strong>upper back</strong>, <strong>neck</strong>, and <strong>shoulders</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/03/88888.jpg\" style=\"height:847px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">S<strong>cleredema</strong>, a <strong>connective tissue disorder</strong> associated with <strong>diabetes</strong> and characterized by <strong>dermal thickening</strong>, does <strong>not</strong> typically present <strong>with sclerodactyly</strong> and <strong>Raynaud&rsquo;s phenomenon</strong>, which are features of <strong>systemic sclerosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Bolognia 4<sup>th</sup> Edition, Chapter 46, Page No 870</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rooks&rsquo; Textbook of Dermatology- 9<sup>th</sup> Edition Chapter 59 Page No 59.09 - 59.11.</span></strong></span></span></p>",
      "correct_choice_id": 136560,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34187,
      "choices": [
        {
          "id": 136579,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-d, 2-a, 3-b, 4-c</span></span></span></p>"
        },
        {
          "id": 136580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-c, 2-a, 3-b, 4-d</span></span></span></p>"
        },
        {
          "id": 136581,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-c, 2-a, 3-d, 4-b</span></span></span></p>"
        },
        {
          "id": 136582,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1-a, 2-c, 3-b, 4-d</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following Drugs in Column A with the Colour of pigmentation associated in Column B?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-151917.jpg\" style=\"height:372px; width:1000px\" /></span></span></p>",
      "unique_key": "Q9771503",
      "question_audio": null,
      "question_video": null,
      "map_id": 22664,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 1-c, 2-a, 3-b, 4-d</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-152250.jpg\" style=\"height:349px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Arsenic&nbsp;</span></strong><span style=\"font-size:12.0pt\">exposure can lead to <strong>raindrop pigmentation</strong> of the skin, which presents as Small Areas of Hyperpigmentation resembling Raindrops.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Minocycline,&nbsp;</span></strong><span style=\"font-size:12.0pt\">a <strong>tetracycline antibiotic</strong>, can cause <strong>blue-black pigmentation</strong> in Acne Scars, on the Face, and in areas of previous Inflammation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture22_ZU06vjf.jpg\" style=\"height:277px; width:350px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. Chlorpromazine</span></strong><span style=\"font-size:12.0pt\">, an <strong>Antipsychotic </strong>medication, can lead to <strong>Blue-Grey Pigmentation</strong> typically occurring after prolonged use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Clofazimine</span></strong><span style=\"font-size:12.0pt\">, used to treat <strong>Leprosy</strong>, is known to cause <strong>Brown Pigmentation</strong> of the Skin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture23_0cKyFpo.jpg\" style=\"height:467px; width:350px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug-Induced Pigmentation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-152843.jpg\" style=\"height:569px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Systemic causes of hyperpigmentation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cushing Disease, Addisons, Grave&#39;s Disease</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemochromatosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Megaloblastic Anemia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pernicious Anemia</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pregnancy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal Failure</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic Sclerosis</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>clinical recognition</strong> of <strong>drug-induced skin pigmentation</strong> requires matching the characteristic <strong>color change</strong> with the <strong>causative agent</strong>: <strong>Arsenic</strong> causes <strong>raindrop pigmentation</strong>; <strong>Minocycline</strong> leads to <strong>blue-black pigmentation</strong>; <strong>Chlorpromazine</strong> results in <strong>blue-grey pigmentation</strong>; and <strong>Clofazimine </strong>causes <strong>brown pigmentation</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Page no 88.17, 88.25</span></strong></span></span></p>",
      "correct_choice_id": 136580,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34191,
      "choices": [
        {
          "id": 136595,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lifting the Scale Reveals Spikes on Under Surface</span></span></span></p>"
        },
        {
          "id": 136596,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pinpoint Bleeding is visible on Removal of Scales</span></span></span></p>"
        },
        {
          "id": 136597,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scratching the Lesion will make the Scales more Apparent</span></span></span></p>"
        },
        {
          "id": 136598,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Stretching the Skin, Scales tend to Fold along the Line of Stretch</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 37-year-old female presented with lesions on face and concha as shown in the pictures below. The lesions are associated with scaling and are non-pruritic. Which of the following is a characteristic finding in this condition? </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/screenshot-2024-01-30-154647_aCTuesv.jpg\" style=\"height:164px; width:300px\" /></span></span></p>",
      "unique_key": "Q8340618",
      "question_audio": null,
      "question_video": null,
      "map_id": 22668,
      "difficulty_level": "difficult",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Lifting the Scale Reveals Spikes on Under Surface.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. </span></strong><span style=\"font-size:12.0pt\">The <strong>clinical description</strong> and <strong>image</strong> are consistent with <strong>Discoid Lupus Erythematosus (DLE)</strong>, a chronic form of <strong>cutaneous lupus</strong>. The characteristic finding in DLE is the presence of <strong>&quot;carpet tack&quot;</strong> <strong>spikes</strong> on the <strong>under surface</strong> of the <strong>scales</strong>, which are <strong>remnants</strong> of <strong>follicular plugs</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pinpoint bleeding is visible on removal of scales</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pinpoint bleeding&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">upon <strong>removal of scales</strong>, known as the <strong>Auspitz sign</strong>, is typically seen in <strong>psoriasis</strong> when the <strong>thin layers</strong> overlying the <strong>dilated dermal papillae</strong> are <strong>removed</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture24_E9VFjjE.jpg\" style=\"height:230px; width:350px\" /></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Scratching the lesion will make the scales more apparent</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>grattage test</strong>, where scratching a <strong>psoriatic lesion</strong> leads to <strong>more prominent scales</strong>, is suggestive of <strong>psoriasis</strong>, not DLE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Stretching the skin, scales tend to fold along the line of stretch</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>collarette scale</strong>, which is a <strong>fine scale</strong> that seems to <strong>fold</strong> along the <strong>line of stretch</strong>, is characteristic of <strong>pityriasis rosea</strong>, not DLE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In <strong>Discoid Lupus Erythematosus</strong>, <strong>lifting</strong> the <strong>scale reveals spikes</strong> on the <strong>undersurface,</strong> which are the <strong>remnants of follicular plugs</strong>, distinguishing this condition from <strong>psoriasis</strong> and <strong>pityriasis rosea</strong> which have <strong>different characteristic scale findings</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Page No 51.5</span></strong></span></span></p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bolognia Textbook of Dermatology 4<sup>th</sup> Edition Page No 1166</span></span></strong></p>",
      "correct_choice_id": 136595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34193,
      "choices": [
        {
          "id": 136603,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Ro/SSA and Anti-La/SSB Antibodies </span></span></span></p>"
        },
        {
          "id": 136604,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Double-Stranded DNA (dsDNA) Antibodies </span></span></span></p>"
        },
        {
          "id": 136605,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Centromere Antibodies </span></span></span></p>"
        },
        {
          "id": 136606,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Smooth Muscle Antibodies</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old woman presents to the clinic complaining of a widespread rash that has been worsening over the past month. She notes that the rash gets more pronounced when she spends time in the sun. Physical examination reveals multiple annular, erythematous plaques with central clearing and slight scale, distributed over her chest and back as shown below. She denies any joint pain or systemic symptoms. Laboratory tests are ordered, and her serological studies are pending.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following antibodies is most characteristic of this condition?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture11_ajEg3gJ.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q2153434",
      "question_audio": null,
      "question_video": null,
      "map_id": 22670,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Anti-Ro/SSA and Anti-La/SSB Antibodies:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anti-Ro/SSA and Anti-La/SSB antibodies</span></strong><span style=\"font-size:12.0pt\">: This is the <strong>correct answer</strong>. The patient&#39;s presentation is suggestive of <strong>subacute cutaneous lupus erythematosus (SCLE)</strong>, which is typically associated with Anti-Ro/SSA and Anti-La/SSB antibodies. These antibodies are also seen in <strong>Sj&ouml;gren&#39;s syndrome</strong> but the rash is characteristic of SCLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anti-Double-Stranded DNA (dsDNA) Antibodies</span></strong><span style=\"font-size:12.0pt\">: Anti-dsDNA antibodies are <strong>highly specific</strong> for <strong>Systemic Lupus Erythematosus (SLE)</strong> and are typically associated with more severe disease, including <strong>renal</strong> <strong>involvement</strong>, which is not indicated in this patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anti-Centromere Antibodies</span></strong><span style=\"font-size:12.0pt\">: Anti-centromere antibodies are most commonly associated with <strong>limited cutaneous systemic sclerosis (lcSSc)</strong>, previously known as <strong>CREST syndrome</strong>, which does not present with the annular plaques seen in SCLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anti-Smooth Muscle Antibodies</span></strong><span style=\"font-size:12.0pt\">: Anti-smooth muscle antibodies are often associated with <strong>autoimmune hepatitis</strong>, which does not present with the cutaneous findings described for this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antibodies and Associated Diseases in SLE and Other Conditions</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/03/333.jpg\" style=\"height:459px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In <strong>Subacute Cutaneous Lupus Erythematosus (SCLE), Anti-Ro/SSA and Anti-La/SSB</strong> antibodies are characteristic <strong>serological findings</strong>, and these patients often present with <strong>photosensitive annular plaques</strong> with <strong>central clearing</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Page No 51.13</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bolognia Textbook of Dermatology 4<sup>th</sup> edition Page No 668</span></strong></span></span></p>",
      "correct_choice_id": 136603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34195,
      "choices": [
        {
          "id": 136611,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anagen Effluvium </span></span></span></p>"
        },
        {
          "id": 136612,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Discoid Lesions </span></span></span></p>"
        },
        {
          "id": 136613,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Painful Oral Ulcers </span></span></span></p>"
        },
        {
          "id": 136614,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Raccoon Eyes</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 28-year-old woman presents to the dermatology clinic with complaints of hair loss and skin lesions. She reports that the skin lesions have been present for several months and often feel tender. She has also noticed sores in her mouth. Her medical history is significant for joint pain and fatigue. On examination, you note several round, well-defined plaques with erythema, scale, and central scarring on her scalp. The patient also has diffuse, non-scarring alopecia. No lymphadenopathy is palpable.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following findings is most characteristic of systemic lupus erythematosus (SLE) in this patient?</span></span></span></p>",
      "unique_key": "Q1502412",
      "question_audio": null,
      "question_video": null,
      "map_id": 22672,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Discoid Lesions:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><span style=\"font-size:12.0pt\">Discoid lesions are a <strong>hallmark of chronic cutaneous lupus erythematosus</strong>, which can occur in the setting of <strong>SLE</strong>. These lesions are characterized by <strong>round, well-defined, erythematous plaques </strong>with <strong>scale</strong> and <strong>central scarring</strong>, particularly on the scalp, as described in this patient&#39;s presentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anagen Effluvium&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anagen effluvium is a form of <strong>hair loss</strong> that occurs during the <strong>anagen</strong> or <strong>growth phase</strong> of the <strong>hair cycle</strong>, usually due to <strong>chemotherapy. </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is not a characteristic finding in SLE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Painful Oral Ulcers</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral ulcers in <strong>SLE are painless</strong>, which helps differentiate them from other types of ulcers. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture22_NeQoSNk.jpg\" style=\"height:234px; width:350px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While <strong>painful oral ulcers</strong> can occur in SLE, they are not as specific or characteristic as discoid lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Raccoon Eyes</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Raccoon eyes, or bilateral periorbital ecchymosis</span></strong><span style=\"font-size:12.0pt\">, are typically associated with <strong>Neonatal SLE</strong>, basal <strong>skull fractures </strong>or certain types of <strong>amyloidosis</strong>, not in adult forms of SLE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/03/1111.jpg\" style=\"height:280px; width:350px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Discoid lesions</strong>&nbsp;is characteristic <strong>cutaneous manifestations</strong> of <strong>SLE</strong>, which present as <strong>well-defined</strong>, <strong>erythematous plaques</strong> with <strong>scaling</strong> and <strong>central scarring</strong> on the <strong>scalp.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rooks textbook of dermatology- 9<sup>th</sup> Edition page no 51.15</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bolognia Textbook of Dermatology 4<sup>th</sup> edition Page no 672</span></strong></span></span></p>",
      "correct_choice_id": 136612,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34197,
      "choices": [
        {
          "id": 136619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gottron&#39;s Papules - Juvenile Dermatomyositis</span></span></span></p>"
        },
        {
          "id": 136620,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rheumatoid Nodules - Juvenile Rheumatic Arthritis</span></span></span></p>"
        },
        {
          "id": 136621,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sclerodactyly - Systemic Sclerosis</span></span></span></p>"
        },
        {
          "id": 136622,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mechanic&#39;s Hand - Systemic Lupus Erythematosus</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical finding in the 10-year-old boy includes fever, joint pain, and a hand lesion as shown in the image below. What is the likely diagnosis based on these findings?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture44.jpg\" style=\"height:267px; width:300px\" /></span></span></p>",
      "unique_key": "Q4737466",
      "question_audio": null,
      "question_video": null,
      "map_id": 22674,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Gottron&#39;s Papules - Juvenile Dermatomyositis.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Gottron&#39;s Papules - Juvenile Dermatomyositis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Juvenile Dermatomyositis&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a rare <strong>inflammatory</strong> disease affecting the <strong>skin</strong> and <strong>muscles</strong>. It typically presents in children with a characteristic <strong>skin rash</strong> and <strong>muscle weakness</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gottron&#39;s papules&nbsp;</span></strong><span style=\"font-size:12.0pt\">are distinctive <strong>red or violet</strong>, <strong>raised</strong>, <strong>scaly lesions</strong> seen over <strong>knuckles (</strong><strong>dorsal interphalangeal</strong> or <strong>metacarpophalangeal joints</strong>)<strong>, elbows, knees</strong>, and other <strong>extensor</strong> surfaces, highly suggestive of <strong>dermatomyositis</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of <strong>fever, joint pain, and Gottron&#39;s papules strongly indicates juvenile dermatomyositis.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">The Gottron&#39;s sign&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a distribution of <strong>symmetric</strong>, <strong>non-scaling</strong>, <strong>violaceous, erythematous macules or plaques</strong> that are frequently <strong>atrophic</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture55.jpg\" style=\"height:235px; width:350px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gottron&#39;s sign seen in the above image</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Shawl Sign or V-Sign:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Fixed <strong>Macular Erythema</strong> spanning the <strong>Shoulders</strong> and <strong>Outer Arms</strong> (Shawl distribution) as seen in the image below</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture66.jpg\" style=\"height:272px; width:350px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Periungual Telangiectasias:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Enlarged Capillaries in the <strong>Nail Folds</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture77.jpg\" style=\"height:259px; width:350px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanic&#39;s Hand: Roughening&nbsp;</span></strong><span style=\"font-size:12.0pt\">and Cracking of the <strong>Fingertip</strong> and <strong>Side</strong> Skin that results in <strong>Scuffed, Crooked lines</strong> that resemble those of a <strong>Mechanic or Manual Laborer.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture88.jpg\" style=\"height:261px; width:350px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Proximal myopathy:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Patients have <strong>trouble performing everyday activities</strong> like <strong>climbing stairs, getting up</strong>, and <strong>lifting their arms</strong> above their heads.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Laboratory evaluation&nbsp;</span></strong><span style=\"font-size:12.0pt\">of patients with <strong>dermatomyositis</strong> will reveal <strong>elevated serum creatinine kinase</strong> and <strong>antinuclear antibodies. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Rheumatoid Nodules - Juvenile Rheumatoid Arthritis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Juvenile Rheumatoid Arthritis&nbsp;</span></strong><span style=\"font-size:12.0pt\">is an <strong>Autoimmune disorder </strong>causing <strong>chronic</strong> <strong>joint inflammation </strong>in <strong>children.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rheumatoid Nodules&nbsp;</span></strong><span style=\"font-size:12.0pt\">are <strong>Firm, Painless</strong>, <strong>Subcutaneous nodules </strong>that usually occur in areas of <strong>pressure</strong> but are <strong>not typically </strong>seen in the <strong>hands</strong> in this form.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture99.jpg\" style=\"height:336px; width:250px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rheumatoid arthritis and rheumatoid nodules. Note the periarticular location of the skin- coloured nodules .</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesion in the image <strong>doesn&#39;t match</strong> the <strong>typical appearance</strong> of <strong>rheumatoid nodules</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sclerodactyly - Systemic Sclerosis:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Systemic Sclerosis&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a <strong>connective tissue</strong> disease characterized by skin <strong>thickening</strong> and <strong>hardening (scleroderma).</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sclerodactyly&nbsp;</span></strong><span style=\"font-size:12.0pt\">refers to <strong>thickening and tightening</strong> of the skin on the <strong>fingers</strong> and <strong>hands</strong>, leading to a <strong>claw-like appearance</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesion shown <strong>doesn&#39;t indicate</strong> the <strong>skin thickening</strong> or <strong>tightness characteristic</strong> of <strong>sclerodactyly</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Mechanic&#39;s Hand - Systemic Lupus Erythematosus (SLE):</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">SLE&nbsp;</span></strong><span style=\"font-size:12.0pt\">is an <strong>autoimmune</strong> disease affecting <strong>multiple organ</strong> systems.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mechanic&#39;s hand&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a sign associated more with <strong>dermatomyositis</strong> than SLE, characterized by <strong>rough, cracked skin</strong> on the sides of the <strong>fingers,</strong> mimicking the hands of a <strong>manual labourer</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presentation of mechanic&#39;s hand in SLE is <strong>less common</strong> and the symptoms described do not align well with SLE.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a case involving <strong>fever, joint pain, and hand lesions in a child</strong>, the presence of <strong>Gottron&#39;s papules</strong> is indicative of <strong>Juvenile dermatomyositis</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology- 9<sup>th</sup> Edition Chapter 53 Page no 53.1-53.12</span></strong></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harrison&rsquo;s Principles of Internal Medicine 21<sup>st</sup> Edition Page 2820-2821</span></span></strong></p>",
      "correct_choice_id": 136619,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 34198,
      "choices": [
        {
          "id": 136623,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Associated with Herpes Simplex</span></span></span></p>"
        },
        {
          "id": 136624,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Associated with Sulphonamides</span></span></span></p>"
        },
        {
          "id": 136625,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lesions are Symmetrical</span></span></span></p>"
        },
        {
          "id": 136626,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">EM Minor has Mucosal Involvement</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old male presents to the emergency department with a rapidly developing rash. He reports a recent history of herpes simplex virus infection and has been taking a sulphonamide antibiotic for a urinary tract infection. Physical examination reveals multiple round lesions with a typical target or &quot;iris&quot; appearance, centrally darkened with concentric rings, located on his palms and soles. Some of the lesions are also noted on his trunk and face. The patient denies any respiratory or gastrointestinal symptoms. All are true about EMF except?</span></span></p>",
      "unique_key": "Q8909375",
      "question_audio": null,
      "question_video": null,
      "map_id": 22675,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) EM Minor has Mucosal Involvement</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is the correct answer as the statement is <strong>false</strong>. <strong>EM minor</strong> typically <strong>does</strong> <strong>not involve mucosal surfaces</strong>; mucosal involvement is more characteristic of <strong>EM major or Stevens-Johnson syndrome</strong>, which represents a <strong>more severe form of the disease.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture101.jpg\" style=\"height:177px; width:400px\" /></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Associated with Herpes Simplex</span></strong><span style=\"font-size:12.0pt\">: Erythema Multiforme (EM) is frequently associated with <strong>herpes simplex virus (HSV) infections</strong>. HSV is one of the most common precipitating factors for EM. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Associated with Sulphonamides</span></strong><span style=\"font-size:12.0pt\">: EM can be associated with <strong>reactions</strong> to certain medications, including <strong>sulphonamides</strong>, which are known to be a <strong>common drug trigger.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Lesions are Symmetrical</span></strong><span style=\"font-size:12.0pt\">: The lesions in EM are typically <strong>symmetrical</strong> and often present with a <strong>classic target or iris appearance</strong>, as described in the vignette. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture1111.jpg\" style=\"height:224px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></u></strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Erythema multiforme minor</strong> is characterized by <strong>target lesions</strong> <strong>without mucosal</strong> involvement, unlike erythema multiforme major, which does include mucosal lesi</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ons. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EM can be <strong>triggered by infections</strong> such as <strong>Herpes Simplex</strong> <strong>Virus</strong> and <strong>medications</strong> like <strong>Sulphonamides</strong> and the lesions are <strong>typically symmetrical.</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Rook&#39;s Textbook of Dermatology 9th Edition Chapter 47, Page no 47.1-5</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bolognia Textbook of Dermatology 4<sup>th</sup> Edition Page no 323</span></span></strong></span></span></p>",
      "correct_choice_id": 136626,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}